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Abstract
Background: Canine reticulated platelets (r-PLTs) i.e., juvenile PLTs reflecting thrombopoiesis can be measured
automatically with the hematology analyzer Sysmex XT-2000iV using manual gating options. However, the impact
of interferences on r-PLT measurements performed with the gates published previously (Pankraz et al., Vet Clin Path
38:30–38, 2009; Gelain et al., High fluorescent platelets fraction in macrothrombocytopenic Norfolk terrier, 2010) is
largely unknown.
The aim was to compare different published gates for measurement of r-PLTs with the Sysmex XT-2000iV with an
own, optimized gate (“Oellers-gate”) and to establish reference intervals (RIs) in > 120 dogs.
Data of 362 measurements of diseased and healthy dogs were analyzed retrospectively. Several gates were applied
and RIs for r-PLTs and platelet indices were established for pet dogs and a group of 153 healthy Beagles kept under
defined housing conditions. Intra-assay precision (CV) was also assessed.
Results: In 30/362 samples, interferences consistent with small erythrocytes/reticulocytes were seen in the previously
published gates but not in the “Oellers-gate”. Good correlation was found between the different gates (rs: 0.88–1.00).
RIs for the “Pankraz-gate”, the “Gelain-gate”, and the “Oellers-gate” were 0.0–1.2, 0.2–3.7 and 0.2–3.9 % respectively. CVs
were ranging between 22 and 41 %.
Conclusions: Optimization of previously published gates minimized interferences of small erythrocytes with r-PLT
measurements.
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Background
Canine reticulated platelets (r-PLTs) i.e., juvenile plate-
lets were first described in 1969 following acute blood
loss in dogs [1]. Later, r-PLTs were detected with flow
cytometry using Thiazol Orange [2] comparable to the
measurement of reticulocytes [3]. Thiazol Orange posi-
tive platelets are shown to be less than 24 h old [4], so
that their measurement is useful to estimate the platelet
production by the bone marrow as it has been shown
for human patients [5, 6]. Megakaryopoiesis can be esti-
mated by evaluating a bone marrow aspirate or biopsy;
however, taking a blood sample is much easier, less
invasive and therefore the better choice for a continuous
monitoring of the patient. Moreover, evaluation of bone
marrow samples is subjective, time consuming and re-
quires a highly skilled examiner. Measuring r-PLTs in
whole blood using flow cytometry with Thiazol Orange
is noninvasive and objective, but the method is both ex-
pensive and time-consuming. The Sysmex XE-2100 and
the closely related Sysmex XT-2000iV are automated
hematology analyzers designed for their use in human
and animal specimens, respectively. Both analyzers
measure platelets by impedance (PLT-I) and laser based
methods (PLT-O). Due to its option of manual gating,
the Sysmex analyzer XT-2000iV is capable of detecting
immature r-PLTs by flow cytometry in the PLT-O chan-
nel, whereby a proprietary dye containing polymethine
and oxazine is applied. The dye penetrates cell mem-
branes and stains nucleic acids in reticulocytes and
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immature platelets. These cells are classified by flow cy-
tometry based on their size (forward light scatter) and
their fluorescence intensity (nucleic acid content) [7].
Since 2009, the detection of r-PLTs in dogs with the Sys-
mex XT-2000iV automated hematology analyzer has
been evaluated and a reference interval has been estab-
lished (n = 40 dogs [8] and 86 dogs respectively [9]).
Similar to human medicine [10], a large reference
population of > 120 reference individuals has been rec-
ommended also in veterinary medicine to reliably estab-
lish reference intervals (ASVCP recommendations) [11].
To the authors’ knowledge, reference intervals based on
such a large reference population have not been estab-
lished for r-PLTs and platelet indices for the Sysmex XT-
2000iV (thereafter XT-2000iV) analyzer before. More-
over, the impact of potentially interfering cell popula-
tions such as small erythrocytes and reticulocytes on r-
PLT measurements performed with the manual gates
published previously is largely unknown.
Several platelet indices such as mean platelet vol-
ume (MPV), platelet distribution width (PDW), plate-
let large cell ratio (P-LCR) and plateletcrit (PCT) are
provided automatically by the XT-2000iV with each
measurement. The diagnostic use of platelet indices
reflecting platelet size as marker for juvenile platelets
has been controversially discussed [12–17]. We previ-
ously demonstrated that there was no difference be-
tween platelet indices assessed with the XT-2000iV in
thrombocytopenic dogs and controls despite a signifi-
cantly higher percentage of r-PLTs observed in the
diseased dogs [8]. However, the number of dogs eval-
uated previously was comparatively small (n = 40 con-
trol dogs, n = 8 thrombocytopenic dogs) so that a
potential association between mean platelet volume
(MPV) and the number of r-PLTs might have been
missed. In contrast, the MPV was significantly higher
in dogs with immune mediated thrombocytopenia
than in healthy control dogs [18].
Fig. 1 Schematic diagram showing the applied gates: “Gelain-gate” (a), “Pankraz-gate” (b) and “Oellers-gate” (c). Abbreviations: FSC, forward scatter;
SFL, fluorescence intensity; RBC, erythrocytes; LFR, MFR, HFR, low, medium and high fluorescence ratio of reticulocytes; PLT, platelets; r-PLT, reticulated
platelets; PLT-O total, green gate with all optically measured platelets; red gate, gate with r-PLTs; pink gate 4, gate with frequent interferences in the
“Gelain-gate” and “Pankraz-gate”; white gate, can be ignored, not part of respective measurements
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The aims of our study were 1) to compare an opti-
mized gate with the two previously published gating
methods [8, 9], 2) to assess the impact of potentially
interfering cellular populations on r-PLT measurements,
3) to optimize the gates for measurement of r-PLTs with
the XT-2000iV to eliminate possible interferences, and
4) to establish reference intervals for r-PLTs measured
with the own and the previously published gating methods
as well as for platelet indices in a reference population of >
120 dogs as recommended by the ASVCP [11].
Methods
Data of 362 canine complete blood cell counts (CBCs)
including 14 follow-up samples was analyzed retrospect-
ively. Follow-up samples are defined as blood samples,
which have been taken from the same diseased dog but
at different dates. The blood samples have been collected
between July 2006 and April 2007 in the department of
veterinary clinical sciences, Giessen, Germany and be-
tween June 2009 and February 2010 in the department
of Global Non-Clinical Safety, Merck Serono, Darmstadt,
Germany. Overall, 169/362 samples were obtained from
diseased dogs and 193/362 samples were taken from
healthy dogs respectively.
Analysis of r-PLTs and PLT parameters
Measurement was performed with ethylenediamine tetra-
acetic acid (EDTA) anticoagulated blood samples using
the XT-2000iV hematology analyzer and the veterinary
software version 00–08 and 00–10. The retrospective ana-
lysis and gating was performed using the veterinary soft-
ware version 00–11. To detect the number of r-PLTs in
the blood samples, we created one gate to quantify the
whole platelet population (Fig. 1 and 2, PLT-O total) and
another gate located inside the first gate (Figs. 1 and 2,
red gate) containing the r-PLTs. A modified version of
the “Gelain-gate” was created to optimize the separ-
ation between mature and r-PLTs as well as to exclude
erythrocytes and reticulocytes. This modified gate
(“Oellers-gate”, Fig. 1c) was compared with the gates
published by Pankraz et al. and Gelain et al. (“Pankraz-
gate” Fig. 1b and Fig. 2b and e, “Gelain-gate” Fig. 1a
and Fig. 2a and d). The risk of small erythrocytes and/
or reticulocytes causing clinically important interfer-
ences and thus a false r-PLT count was given when gate
Fig. 2 Scattergrams of the PLT-O channel of the Sysmex XT-2000iV analyzing whole blood samples of a healthy dog (a-c) and a dog with increased
platelet and r-PLT count (d-f). The applied gates are shown schematically. PLT Total detects all platelets, (a, d) r-PLT “Gelain – gate” based on
publication of Gelain et al., (b, e) r-PLT “Pankraz-gate” based on the publication of Pankraz et al., (c, f) r-PLT “Oellers-gate” shows the novel area
for counting r-PLTs. Abbreviations: FSC, forward scatter; SFL, fluorescence intensity
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4 (Fig. 1) contained more than 5 % of the sum of dots
measured in gates 1 and 4. The suspicion of potential
interferences of small erythrocytes/reticulocytes with
the r-PLT count was confirmed by visual control of the
matching scattergram.
Retrospective analysis of each CBC included the fol-
lowing variables: platelet count by optical (PLT-O) and
impedance methods (PLT-I), MPV, platelet distribution
width (PDW), platelet large cell ratio (P-LCR), and plate-
letcrit (PCT).
The analyzer-specific canine reference intervals estab-
lished previously for the XT-2000iV [19] were used as
cut-off values to define anemia or regeneration of eryth-
rocytes (i.e., anemia was diagnosed when the RBC count
was < 5.1 × 1012/L and a reticulocyte count > 150.1 × 109/
L was considered regenerative).
Reference population
The CBCs obtained from healthy dogs (n = 193, one
sample per dog) included mainly samples taken from
healthy Beagle dogs (153/193) obtained from one
breeder (Marshall BioResources, USA). The Beagle
dogs were kept under defined housing conditions: For
20 h a day, they were housed in groups of three to five
dogs. Each dog spent the remaining four hours sepa-
rated from the others in a standard kennel of 6.54 m2
and natural light. The Beagle dogs were fed once a day
with 300 g of a commercially available pelleted dry
food (Provimi Kliba AG, Kaiseraugust, Switzerland).
Water was offered ad libitum. All Beagle dogs were
dewormed and vaccinated against canine distemper,
leptospirosis, canine parvovirus, parainfluenza, Bordetella,
canine adenovirus 2, and rabies.
The other 40/193 healthy dogs kept as pet dogs were
of various breeds including mixed-breed dogs (n = 17),
Border Collies (n = 6), Great Danes (n = 3), West High-
land White Terrier (n = 2), and one Beagle dog, Berger
Blanc Suisse, Cocker Spaniel, Dalmatian, German Shep-
herd, Golden Retriever, Groenendael, Jack Russel Terrier,
Labrador Retriever, Old German Shepherd Dog, Rough
Collie, and Small Munsterlander each.
Statistical analysis
Data was analyzed using Microsoft Excel®, Reference
Value Adviser© version 2.1 for Microsoft Excel®,
Analyse-it® version 2.04 for Microsoft Excel®, and
GraphPad Prism® version 6. Data distribution was
assessed visually with a histogram.
Spearman’s rank correlation, Passing-Bablok-Analysis,
and Bland-Altman-Analysis were performed to deter-
mine correlation and bias between r-PLTs measurements
obtained with the various gates. A Kruskal-Wallis-Test
was used to assess the impact of the gating method
on r-PLT results, whereby the P values were adapted
for multiple comparisons. Level of significance was
set at P < 0.05.
Intra-assay repeatability was assessed by 25 repeated
measurements of one blood sample. For platelet indices,
the XT-2000iV did not report results in 18/25 measure-
ments so that calculation of intra-assay CV was based
on 7 results.
Table 1 Classification in categories of underlying etiology in
diseased dogs
Category of disease Absolute number
(percentage)
Inflammatory diseases 31 (19.87 %)
Cardiovascular diseases 20 (12.82 %)
Neoplasia 18 (11.54 %)
Diseases of the musculoskeletal system 17 (10.90 %)
Monitoring after surgery 8 (5.13 %)
Immune-mediated diseases
- Immune mediated anemia (n = 4/8)
- Immune mediated thrombocytopenia
(n = 3/8)
- Evans syndrome (n = 1/8)
8 (5.13 %)
Portosystemic shunt 6 (3.85 %)
Diseases of the central nervous system 4 (2.56 %)
Non-regenerative anemia 4 (2.56 %)
DIC 2 (1.28 %)
Endocrinologic disease 2 (1.28 %)
Thrombosis 2 (1.28 %)
Regenerative anemia (unknown etiology) 1 (0.64 %)
Hemolytic anemia (unknown etiology) 1 (0.64 %)
Other diseases 32
Abbreviations: DIC disseminated intravascular coagulation
Table 2 Correlation and differences between the different gates for canine r-PLT measurement (n = 362) of the Sysmex XT-2000iV
Variable rs Slope (95 % CI) Intercept (95 % CI) Bias (95 % limits of agreement) Adjusted P-value
r-PLT “Gelain-gate”(%) vs. r-PLT “Oellers-gate”(%) 1.00 1.01 (1.01–1.01) 0.00 (0.00–0.00) 0.1 (−1.3–1.6) ns
r-PLT “Pankraz-gate”(%) vs. r-PLT “Gelain-gate”(%) 0.89 2.83 (2.70–2.99) 0.18 (0.12–0.23) 2.0 (−4.3–8.3) <0.0001
r-PLT “Pankraz-gate”(%) vs. r-PLT “Oellers-gate”(%) 0.88 2.92 (2.78–3.11) 0.17 (0.10–0.22) 2.1 (−4.9–9.2) <0.0001
Abbreviations: CI confidence interval, ns not significant, vs. versus
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Reference intervals for r-PLTs and platelet indices were
generated for all healthy dogs independent of the breed
(n = 193), and also for the subgroups “Beagles” (n = 153)
and “non-Beagles” (n = 40). As recommended by the
American Society of Veterinary Clinical Pathology
(ASVCP) [11], the statistical method used for calcula-
tion of the respective reference intervals was chosen
based on the number of dogs included in the respective ref-
erence population and data distribution. The whole group
of healthy dogs (n = 193) and the group of Beagle dogs (n
= 153) included ≥ 120 individuals, so that the nonparamet-
ric method was chosen to calculate reference intervals [11].
The group of pet dogs contained 40 (r-PLT, PLT-O, PLT-I)
and 38 (MPV, PDW, P-LCR, PCT) dogs, respectively.
When the number of samples was 40 ≤ × ≤ 120, the robust
method was chosen for symmetrical (Gaussian) data distri-
bution [11]. In case of non-Gaussian distribution, a Box-
Cox transformation was performed prior to calculation of
reference intervals. Depending on data distribution after
Box-Cox transformation, a the parametric method was
chosen for data with Gaussian distribution, while a non-
parametric method was used in case of non-Gaussian dis-
tribution. As the XT-2000iV did not report MPV, PDW,
P-LCR and PCT for 3/193 healthy dogs, data of merely
38/40 samples was available in the group of “non-Beagles”
for these variables. As recommended previously for refer-
ence populations of < 40 individuals [11], the paramet-
ric method and robust method were used in case of
Gaussian and non-Gaussian distribution, respectively.
For all reference intervals, the 90 % confidence interval
(CI) of the upper and lower ends of the reference limits
was calculated using bootstrap methods.
Table 3 Median, minimum and maximum r-PLT counts of the
analyzed group of healthy and diseased dogs (n = 362)
Variable Median Minimum Maximum
r-PLT “Gelain-gate”(%) 1.33 0.11 54.89
r-PLT “Pankraz-gate”(%) 0.40 0.0 35.02
r-PLT “Oellers-gate”(%) 1.33 0.12 57.34
Fig. 3 Samples of diseased dogs with suspected interferences. (a-b) Differences in the r-PLT percentage between the “Gelain-gate” (a) and the
“Oellers-gate” (b) in a sample with suspected interferences of erythrocytes and reticulocytes. The white arrow shows the difference between the
previously used gates and the novel “Oellers-gate”. (c) A sample with dots suspicious for WBC fragments appearing in the PLT-O channel and the
gate for r-PLTs. Abbreviations: FSC, forward scatter; SFL, fluorescence intensity
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Results
The group of healthy Beagles included dogs with an age
ranging from 10 to 14 months and equally distributed
sex (77/153 intact males and 76/153 intact females).
In the group of healthy “non-Beagles”, 40 dogs (11/40
intact males, 7/40 castrated males, 5/40 intact females, as
well as 17/40 castrated females) with a median age of two
years (range: 4 months to 15 years) were enrolled.
In contrast, the diseased dogs (169/362) had a median
age of seven years ranging between 3 months and
16 years. Overall, 60/169 intact males, 25/169 castrated
males, 42/169 intact females as well as 42/169 castrated
females were included.
In all 362 CBCs obtained from healthy and diseased
dogs, the PLT count ranged between 3 × 109/L and
871 × 109/L. The r-PLT count as measured with the
“Oellers-gate” ranged between 0.12 and 57.34 % in the
whole group of 362 healthy and diseased dogs and be-
tween 0.29 and 57.34 % when regarding the group of
diseased dogs alone (169/362).
The categories of underlying diseases are shown in
Table 1. Overall, 41/169 samples were anemic with RBC
counts < 5.1 × 1012 /L, whereby 19/41 anemic specimen
showed regeneration of erythrocytes at the time of sam-
pling with reticulocyte counts (RET) > 150.1 × 109/L.
All three evaluated gates of the XT-2000iV showed
good correlation as shown in Table 2. The best correl-
ation was found between the “Gelain-gate” and the “Oel-
lers-gate”. There was a small bias between the results
obtained with the “Gelain-gate” and the “Oellers-gate”;
however, the difference was not statistically significant
(Table 2). In contrast, the “Pankraz-gate” differed signifi-
cantly from the two other gates and there was a bias of
approximately 2 %. The corresponding median value
and range are shown in Table 3.
In 30/362 samples, a number of dots exceeding 5 % of
the sum of dots in gates 1 and 4 was found in gate 4
(Fig. 2d and e). In all cases, the visual control of the
matching scattergrams showed an interference of small
erythrocytes and/or reticulocytes. Gate 4 was included in
both the “Gelain-gate” and the “Pankraz-gate” but ex-
cluded in the “Oellers-gate”. In Fig. 3a and b, one of 30
samples with clinically important interferences and their
impact on the r-PLT measurement performed with the
different gating methods is shown.
Furthermore, in 6/362 samples, visual control of the
scattergrams revealed a small number of dots other than
r-PLTs displayed in all evaluated r-PLT gates (Fig. 3c).
These dots were positioned underneath the r-PLT popu-
lation and were consistent with white cell fragments de-
scribed in humans. However, in the present study, they
made up a negligible number of dots.
For measurement of r-PLTs in all three gates, intra-
assay CVs > 22.0 % were obtained. The highest CV of
41.1 % was seen for the “Pankraz-gate”. CVs for PLT-O,
PDW and PCT were 5.6, 6.8 and 4.5 % and thus mark-
edly lower than for r-PLT measurement. For the vari-
ables MPV, P-LCR and PLT-I, CVs < 3 % were obtained
(Table 4). However, in 18/25 measurements, results of
the platelet indices MPV, PDW, P-LCR and PCT were
not reported by the analyzer due to an error in (data)
analysis, so that calculation of the CV was based on only
7 repeated measurements.
The reference intervals for r-PLTs obtained with the
different gates are shown in Table 5. The corresponding
data distribution is demonstrated in Fig. 4. Table 6
shows the reference ranges for platelet indices. Reference
intervals obtained for all dogs irrespective of the breed,
differed evidently from those calculated exclusively for
the population of “Beagles” or “non-Beagles”. Overall,
reference intervals established solely for the Beagle
population showed the smallest range.
In 3/193 healthy dogs (1/153 Beagle and 2/40 non-
Beagle), platelet indices were not reported by the
analyzer due to an error in (data) analysis so that these
three samples could not be included in the calculation of
the respective reference intervals.
Furthermore, the analyzer did not report a result for
the platelet indices in samples with r-PLT percentages
exceeding 11.61 % (19/362) for the “Gelain-gate” and
11.66 % (21/362) for the “Oellers-gate”, respectively. In
samples without reported PLT indices, the platelet histo-
gram was characterized by a relatively indistinctive sep-
aration (“valley”) between erythrocytes and platelets so
Table 4 Intra-assay repeatability of r-PLT and platelet indices
using the Sysmex XT-2000iV
Variable CV (%) Mean ± SD
r-PLT “Gelain-gate”(%) 22.02 6.98 ± 1.54
r-PLT “Pankraz-gate”(%) 41.14 1.81 ± 0.75
r-PLT “Oellers-gate”(%) 22.04 7.02 ± 1.55
r-PLT “Gelain-gate”(× 109/L) 21.36 7.11 ± 1.52
r-PLT “Pankraz-gate”(× 109/L) 40.10 1.84 ± 0.74
r-PLT “Oellers-gate”(× 109/L) 21.38 7.1 ± 1.52
PLT-I (× 109/L) 2.98 128.32 ± 3.83
PLT-O (× 109/L) 5.56 121.2 ± 6.73
MPV (fL) 1.86 13.2 ± 0.24
PDW (fL) 6.75 17.77 ± 1.20
P-LCR (%) 2.72 47.7 ± 1.30
PCT (%) 4.52 0.17 ± 0.01
r-PLT, PLT-I, PLT-O: n = 25 repeated measurements
MPV, PDW, P-LCR, PCT: n = 7 repeated measurements
Abbreviations: CV coefficient of variation, SD standard deviation, PLT-I platelet
count with impedance, PLT-O platelet count in optical fluorescence analysis,
MPV mean platelet volume, PDW calculated distribution width of platelets,
P-LCR platelet-large cell ratio, PCT plateletcrit, L liter, fL femtoliter
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Table 5 Reference ranges for reticulated platelets (r-PLT) in healthy dogs independent of the breed as well as in Beagles and non-Beagles using the Sysmex XT-2000iV
Variable All dogs (n = 193) Beagles (n = 153) Non-Beagles (n = 40)
2.5th Percentile
(90 % CI)
97.5th Percentile
(90 % CI)
Method 2.5th Percentile
(90 % CI)
97.5th Percentile
(90 % CI)
Method 2.5th Percentile
(90 % CI)
97.5th Percentile
(90 % CI)
Method
r-PLT “Gelain-
gate”(%)
0.2 (0.1–0.3) 3.7 (2.7–6.9) Nonparametric 0.2 (0.1–0.3) 2.4 (2.1–4.5) Nonparametric 0.2 (0.1–0.3) 6.8 (4.8–9.3) Robust, Box-Cox-
Transformation
r-PLT “Pankraz-
gate”(%)
0.0 (0.0–0.0) 1.2 (1.0–2.2) Nonparametric 0.0 (0.0–0.0) 1.0 (0.7–1.3) Nonparametric 0.0 (0.0–0.0) 2.2 (1.6–2.8) Robust, Box-Cox-
Transformation
r-PLT “Oellers-
gate”(%)
0.2 (0.1–0.3) 3.9 (2.8–7.0) Nonparametric 0.2 (0.1–0.3) 2.4 (2.1–4.5) Nonparametric 0.2 (0.1–0.3) 7.1 (5.0–9.7) Robust, Box-Cox-
Transformation
r-PLT “Gelain-
gate”(× 109/L)
0.4 (0.3–0.6) 5.7 (4.9–8.7) Nonparametric 0.4 (0.3–0.5) 4.2 (3.7–6.5) Nonparametric 0.3 (0.1–0.4) 6.4 (5.0–8.0) Robust, Box-Cox-
Transformation
r-PLT “Pankraz-
gate”(× 109/L)
0.1 (0.0–0.1) 2.1 (1.8–2.9) Nonparametric 0.1 (0.0–0.1) 1.7 (1.4–2.2) Nonparametric 0.0 (0.0–0.1) 3.2 (2.7–3.2) Nonparametric
r-PLT “Oellers-
gate”(× 109/L)
0.4 (0.3–0.6) 5.6 (4.9–8.7) Nonparametric 0.4 (0.3–0.5) 4.2 (3.6–6.4) Nonparametric 0.5 (0.3–0.7) 10.0 (7.5–12.6) Robust, Box-Cox-
Transformation
Abbreviations: CI confidence interval, for remainder abbreviations: see Table 4
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that a reliable differentiation between the cellular popula-
tions could not be ensured by the analyzer’s software.
Discussion
Overall, the retrospective analysis of a large number of
dog CBCs enabled us to optimize the already existing r-
PLT gates by excluding interferences of reticulocytes and
small erythrocytes with the r-PLT measurement.
The significant difference between the “Pankraz-gate”
and the two other gates is presumably a result of its
smaller size. Compared to the other gates, r-PLTs need
to contain more RNA to be detected in the “Pankraz-
gate”. Consequently, the corresponding reference ranges
obtained for the “Pankraz-gate” are much narrower than
for the other gates. The difference between the “Gelain-
gate” and “Oellers-gate” was solely based on samples
where erythrocytes and/or reticulocytes interfered with
the measurement of platelets and r-PLTs. Using the
“Gelain-gate”, these interfering erythrocytes and/or retic-
ulocytes were incorrectly counted as mature platelets,
consequently resulting in a false high total platelet count
obtained with the manual gate and thus a false low per-
centage of r-PLTs. This incorrect cell count is only a
problem of the manual gating technique; however, the
original automated PLT count could not be used for the
purposes of r-PLT measurement. In contrast, the effect
of interferences, i.e., false low r-PLT counts, is minimized
by the novel “Oellers-gate” by excluding the critical
group of cellular populations (Fig. 3a and b).
Another reason for visual examination of the scatter-
grams is the occurrence of another type of interfering
cells within the r-PLT-gate, which were rarely observed
in the present study (Fig. 3c) but have not been de-
scribed previously for dogs. In human medicine, similar
interferences have been reported in patients receiving
chemotherapy and were considered to be white cell frag-
ments [20]. In our study, the definite origin and etiology
of the interferences could not be evaluated.
The r-PLT reference intervals obtained in this study
are consistent with the reference intervals published
Fig. 4 Reference interval and data distributions for r-PLTs of 193 healthy dogs measured with the Sysmex XT-2000iV and three different gating
methods. Blue bars show the observed data distribution, the purple curve represents Gaussian fit. The blue vertical lines are consistent with the
lower and upper limits of the reference interval; the dotted lines indicate the 90 % confidence interval. Abbreviations: r-PLT “Gelain-gate”: gate
based on the publication of Gelain et al.; r-PLT “Pankraz-gate”: gate based on the publication of Pankraz et al., r-PLT “Oellers-gate”: optimized gate
for measurement of r-PLTs
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Table 6 Reference ranges for platelet indices in healthy dogs independent of the breed as well as in Beagles and non-Beagles using the Sysmex XT-2000iV
Variable All dogs (n = 190–193) Beagles (n = 152–153) Non-Beagles (n = 38–40)
2.5th Percentile
(90 % CI)
97.5th Percentile
(90 % CI)
Method 2.5th Percentile
(90 % CI)
97.5th Percentile
(90 % CI)
Method 2.5th Percentile
(90 % CI)
97.5th Percentile
(90 % CI)
Method
PLT-I (×
109/L)
161.8 (149.0–175.0) 425.0 (381.0–438.0) Non-
parametric
176.7 (155.0–194.0) 406.9 (377.0–452.0) Non-
parametric
125.6 (115.5–143.7) 452.0 (405.3–501.8) Robust, Box-Cox-Trans-
formation
PLT-O (×
109/L)
150.9 (141.0–169.0) 397.5 (355.0–416.0) Non-
parametric
172.8 (161.0–184.0) 377.1 (351.0–416.0) Non-
parametric
121.6 (110.6–137.1) 418.9 (375.2–467.7) Robust, Box-Cox-Trans-
formation
MPV (fL) 8.6 (8.3–8.9) 12.5 (12.1–12.8) Non-
parametric
8.8 (8.6–8.9) 12.3 (12.1–13.4) Non-
parametric
7.9 (7.4–8.4) 12.8 (12.3–13.4) Robust
PDW (fL) 8.8 (8.4–9.2) 16.6 (14.7–18.0) Non-
parametric
9.0 (8.7–9.3) 15.4 (14.5–18.0) Non-
parametric
7.9 (7.5–8.6) 18.3 (16.4–20.5) Robust, Box-Cox-
Transformation
P-LCR (%) 14.1 (12.1–15.9) 43.0 (41.3–44.7) Non-
parametric
15.5 (14.1–16.8) 43.1 (41.3–48.2) Non-
parametric
9.1 (5.3–13.1) 45.8 (41.5–49.8) Parametric
PCT (%) 0.2 (0.2–0.2) 0.4 (0.4–0.4) Non-
parametric
0.2 (0.2–0.2) 0.4 (0.4–0.5) Non-
parametric
0.2 (0.1–0.2) 0.4 (0.4–0.5) Robust, Box-Cox-
Transformation
Abbreviations: CI confidence interval; for remainder abbreviations: see Table 4
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previously for the XT-2000iV [8, 9]. Reference intervals
established here for the “Gelain-gate” (0.2–3.7 %; 0.4–
5.7 × 109/L) and the “Oellers-gate” (0.2–3.9 %; 0.4–5.6 ×
109/L) in 193 dogs are comparable with results pub-
lished previously by Gelain et al. [9] (1.4 ± 0.7 %; 4 ±
2.5 × 109/L, n = 86). Furthermore, our reference interval
established for the “Pankraz-gate” (0.0–1.2 %) is in ac-
cordance to the reference range shown previously by
Pankraz et al. for the XT-2000iV [8] (0.56 ± 0.82 %, n = 40).
Our results clearly showed that the reference intervals
in Beagle dogs are much smaller than in non-Beagle dogs,
which is most likely because of the lower genetic variation,
the similar age and the identical housing conditions.
Moreover, the reference intervals published by Smith
et al. for flow cytometry with Thiazol Orange and CD61
[21] are also comparable (1.9 ± 1.2 %; 5.2 ± 3.4 × 109/L,
n = 36) with our results. However, when regarding other
reference intervals for r-PLTs determined flow-
cytometrically with the Thiazol Orange method, there
is a large discrepancy between results reported in the
literature ranging from 3.4 ± 2.0 % (n = 8 dogs) [22] to
9.3 ± 2.7 % (n = 20 dogs) [23] and the respective refer-
ence intervals are generally higher than those obtained
in our study. Overall, it is obvious that reference inter-
vals for flow cytometry differ clearly between different
studies, whereas reference intervals for the XT-2000iV
using similar gates showed good accordance. A possible
cause could be different methodology, i.e., variations in
staining protocols or gating of r-PLTs in laboratories
using flow cytometry [24].
Furthermore, our reference intervals for platelet indi-
ces (n = 190–193, depending on the variable) showed
good accordance with reference ranges published before
for the XT-2000iV (n = 160–182, n = 126–132, depend-
ing on the variable [19, 25]).
However, the study is limited by its retrospective na-
ture so that a comparison with a reference method other
than the previously published gates was not performed.
For interpretation of the reference intervals, it has to be
considered that the group of non-Beagle dogs is also
smaller than recommended by the ASVCP [11] and ref-
erence intervals have to be therefore considered as a
rough estimate.
Despite the optimization of the gating method de-
scribed here, interferences could not be totally avoided.
Only flow cytometric assessment of specifically antibody-
labeled platelets would allow a definite distinction between
platelets and other cellular populations. Another potential
limitation of the gating method applied by us and the pre-
vious authors evaluating the r-PLT count measured by the
Sysmex XT is that the gates are based on visual – and
therefore subjective and potentially imprecise – assess-
ment of the dot plots. Additionally, the position and size
of the gates is fixed, so that in some samples, the shape of
the gates did not entirely match the shape of the total
platelet population. Thus, each measurement should be
verified by visual examination of the scattergram. Ideally,
algorithms would be generated to adapt the gate’s position
to the properties of the platelet population.
Similar to results of previous studies using the Sysmex
XT-2000iV, the platelet indices MPV, PDW, P-LCR and
PCT [8, 19, 25] are frequently not reported by the
analyzer. Because of the retrospective nature of this
study, resampling was not possible so that the intra-
assay repeatability could not be calculated for platelet in-
dices, which is a limitation of this study. It should be
noted that in samples with more than 11.61 % r-PLTs, as
measured with the “Gelain-gate”, no platelet indices
were given. Consequently, the platelet indices cannot be
used to reflect presence of large numbers of young –
presumably large - platelets and consequently a marked
platelet regeneration as has been controversially dis-
cussed in previous studies [12, 16, 26, 27].
Conclusions
In conclusion, we managed to optimize the previously
published gates by excluding interferences from erythro-
cytes. However, visual assessment of the scattergrams
still remains necessary. Future improvement might be
achieved by the generation of algorithms automatically
adapting the gate to the position of the platelet popula-
tion. The use of platelet indices as a marker of PLT re-
generation is questionable as their measurement is often
not reliably possible especially in samples with evidence
of larger numbers of immature PLTs.
The reference intervals obtained from a large population
of Beagle dogs for r-PLTs and platelet indices might become
particularly useful for experimental studies using Beagles.
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